CHICAGO — A Fas inhibitor showed strong efficacy signals and demonstrated in patients with more than 8 days of macula-off rhegmatogenous retinal detachment, according to a study.
In a presentation at Retina Subspecialty Day at the American Academy of Ophthalmology meeting, Durga S. Borkar, MD, MMCi, said that patients with macula-off rhegmatogenous retinal detachment (RRD) can experience vision loss even after surgical repair.
“Many studies have shown that time is vision when it comes to the duration of macula-off status,” she said. “The Scottish Retinal Detachment